Company intelligence / Profile preview

Calmate

Ownership: Private
Development stage: Commercial

Overview

Calmare Therapeutics markets the Calmare® Pain Therapy Device, a non-invasive, non-pharmacological medical device for chronic pain management. The device has FDA 510(k) clearance and CE-mark approval in Europe. It is used in outpatient settings and by U.S. military hospitals for various chronic pain conditions[5].

Therapeutic areas: OncologyDermatologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Mango Tango

Commercial

Indications: Anxiety, Stress

Partnerships

U.S. federal government (preferred vendor to military hospitals)[5]

Beyond the preview

Go deeper on Calmate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmate.

Explore the full profile